Literature DB >> 18483503

Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells.

R A Abela1, J Qian, L Xu, T S Lawrence, M Zhang.   

Abstract

Selective gene transfer to tumor is critical in cancer gene therapy. We previously used ionizing radiation to improve adenovirus uptake in intrahepatic tumors but liver cytotoxicity associated with the viral administration still occurred. Here, we explore the potential of radiation for improving gene delivery by a virus-mimicking nanoparticle, transferrin (Tf)-cationic liposome-DNA complex (Tf-lipoplex). Transduction by Tf-lipoplex was highly efficient in various cell lines and further increased by radiation in a dose- and time-dependent manner. This radiation induction, which was associated with an increase in Tf-lipoplex uptake (3- to 4-folds in hepatocytes WB and lung cancer cells, LLC1), was absent when a Tf-deficient complex was used or abolished by the presence of free Tf, suggesting that Tf receptor (TfR) interaction is required for radiation induction. Radiation (10-20 Gy) markedly induced transgene (LacZ) expression in LLC1 xenografts (3.5- to 7.4-folds), correlating with increased plasmid content and TfR expression in irradiated tumors. Moreover, Tf-lipoplex-mediated gene expression was not observed in the liver or other normal tissues regardless of radiation treatment. We conclude that radiation improves Tf-lipoplex gene delivery selectively to tumor cells both in vitro and in vivo. Our findings may provide insight in developing ligand-specific lipoplex for molecularly targeted cancer gene therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483503      PMCID: PMC2998409          DOI: 10.1038/cgt.2008.26

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  26 in total

Review 1.  Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.

Authors: 
Journal:  Hum Gene Ther       Date:  2002-01-01       Impact factor: 5.695

2.  Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery.

Authors:  Liang Xu; Peter Frederik; Kathleen F Pirollo; Wen-Hua Tang; Antonina Rait; Lai-Man Xiang; Weiqun Huang; Idalia Cruz; Yuzhi Yin; Esther H Chang
Journal:  Hum Gene Ther       Date:  2002-02-10       Impact factor: 5.695

Review 3.  Non-viral gene delivery for p53.

Authors:  K F Pirollo; L Xu; E H Chang
Journal:  Curr Opin Mol Ther       Date:  2000-04

4.  TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene.

Authors:  Henrik Rasmussen; Camilla Rasmussen; Maria Lempicki; Rebecca Durham; Douglas Brough; C Richter King; Ralph Weichselbaum
Journal:  Cancer Gene Ther       Date:  2002-11       Impact factor: 5.987

5.  Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo.

Authors:  O Ishida; K Maruyama; H Tanahashi; M Iwatsuru; K Sasaki; M Eriguchi; H Yanagie
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

6.  Transferrin-facilitated lipofection gene delivery strategy: characterization of the transfection complexes and intracellular trafficking.

Authors:  Nirmal Joshee; Dhundy R Bastola; Pi-Wan Cheng
Journal:  Hum Gene Ther       Date:  2002-11-01       Impact factor: 5.695

Review 7.  Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.

Authors:  L Xu; K F Pirollo; E H Chang
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

Review 8.  Stereotactic body radiation therapy in multiple organ sites.

Authors:  Robert D Timmerman; Brian D Kavanagh; L Chinsoo Cho; Lech Papiez; Lei Xing
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

9.  Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.

Authors:  L Xu; K F Pirollo; W H Tang; A Rait; E H Chang
Journal:  Hum Gene Ther       Date:  1999-12-10       Impact factor: 5.695

10.  Low-density lipoprotein receptor-related protein mediates the endocytosis of anionic liposomes in neurons.

Authors:  Aparna Lakkaraju; Yueh-Erh Rahman; Janet M Dubinsky
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

View more
  6 in total

1.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

Review 2.  Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy.

Authors:  Marcela Tavares Luiz; Jessyca Aparecida Paes Dutra; Larissa Bueno Tofani; Jennifer Thayanne Cavalcante de Araújo; Leonardo Delello Di Filippo; Juliana Maldonado Marchetti; Marlus Chorilli
Journal:  Pharmaceutics       Date:  2022-04-08       Impact factor: 6.525

Review 3.  Targeted drug delivery in pancreatic cancer.

Authors:  Xianjun Yu; Yuqing Zhang; Changyi Chen; Qizhi Yao; Min Li
Journal:  Biochim Biophys Acta       Date:  2009-10-22

4.  Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity.

Authors:  Uyen M Le; Darryl G L Kaurin; Brian R Sloat; Nijaporn Yanasarn; Zhengrong Cui
Journal:  Radiother Oncol       Date:  2008-11-14       Impact factor: 6.280

Review 5.  Polymeric nanomedicine for cancer MR imaging and drug delivery.

Authors:  Chalermchai Khemtong; Chase W Kessinger; Jinming Gao
Journal:  Chem Commun (Camb)       Date:  2009-03-10       Impact factor: 6.222

Review 6.  Barriers to Liposomal Gene Delivery: from Application Site to the Target.

Authors:  Mostafa Saffari; Hamid Reza Moghimi; Crispin R Dass
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.